Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$5 Mln
P/E Ratio
--
P/B Ratio
0.76
Industry P/E
--
Debt to Equity
0.02
ROE
-0.46 %
ROCE
-69.59 %
Div. Yield
0 %
Book Value
6.22
EPS
-7.04
CFO
$-177.10 Mln
EBITDA
$-179.37 Mln
Net Profit
$-165.73 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Arcadia Biosciences (RKDA)
| -43.75 | 12.12 | -34.59 | 59.33 | -55.95 | -54.44 | -- |
|
BSE Sensex
| 2.61 | 3.71 | 5.78 | 8.89 | 11.76 | 20.11 | 11.35 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Arcadia Biosciences (RKDA)
| 88.16 | -71.13 | -73.92 | -58.89 | -53.83 | 72.87 | -42.19 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 76.24 | 9,331.51 | 9.66 | 15.95 | |
| 41.74 | 5,143.55 | 12.83 | 7.67 | |
| 30.25 | 9,240.91 | 52.96 | 1.47 | |
| 53.54 | 3,079.96 | -- | -- |
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as... well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Address: 5950 Sherry Lane, Dallas, TX, United States, 75225 Read more
President, CEO & Director
Mr. Stanley E. Jacot Jr.
President, CEO & Director
Mr. Stanley E. Jacot Jr.
Headquarters
Dallas, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Arcadia Biosciences Inc (RKDA) stood at $ 14 Mln as on 31-Dec-24
The share price of Arcadia Biosciences Inc (RKDA) is $3.33 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Arcadia Biosciences Inc (RKDA) has given a return of -55.95% in the last 3 years.
Arcadia Biosciences Inc (RKDA) has a market capitalisation of $ 5 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Arcadia Biosciences Inc (RKDA) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Arcadia Biosciences Inc (RKDA) and enter the required number of quantities and click on buy to purchase the shares of Arcadia Biosciences Inc (RKDA).
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Address: 5950 Sherry Lane, Dallas, TX, United States, 75225
The CEO & director of Mr. Stanley E. Jacot Jr.. is Arcadia Biosciences Inc (RKDA), and CFO & Sr. VP is Mr. Stanley E. Jacot Jr..
There is no promoter pledging in Arcadia Biosciences Inc (RKDA).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
915
|
|
|
887
|
|
|
491
|
|
|
308
|
| Arcadia Biosciences Inc. (RKDA) | Ratios |
|---|---|
|
Return on equity(%)
|
-73.84
|
|
Operating margin(%)
|
-150.88
|
|
Net Margin(%)
|
-139.5
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Arcadia Biosciences Inc (RKDA) was $0 Mln.
$-0.13
(
